Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Summary

Phase II trial to study the effectiveness of thalidomide in treating patients who have relapsed or refractory low-grade non-Hodgkin's lymphoma. Thalidomide may stop the growth of non-Hodgkin's lymphoma by stopping blood flow to the tumor

Timeline

Start

2001-07

Primary completion

2004-12

Completion

—

Drugs

Indications